Thrombotic complications in critically ill patients with COVID 19.
作者信息
Rosen Raphael J
机构信息
Columbia University College of Physicians and Surgeons, Department of Medicine, United States of America.
出版信息
Thromb Res. 2020 Jul;191:56. doi: 10.1016/j.thromres.2020.04.032. Epub 2020 Apr 30.
Abstract
摘要
相似文献
1
Thrombotic complications in critically ill patients with COVID 19.
Thromb Res. 2020 Jul;191:56. doi: 10.1016/j.thromres.2020.04.032. Epub 2020 Apr 30.
2
The burden of thrombotic complications in critically ill patients with COVID-19: charting the uncharted.
Intern Emerg Med. 2020 Aug;15(5):893-895. doi: 10.1007/s11739-020-02393-1. Epub 2020 Jun 5.
3
Analysis of incidence of thrombotic complications in the presence of competing risks.
Thromb Res. 2020 Jul;191:152. doi: 10.1016/j.thromres.2020.04.045. Epub 2020 May 3.
4
Serial bedside lung ultrasonography in a critically ill COVID-19 patient.
QJM. 2020 Jul 1;113(7):491-493. doi: 10.1093/qjmed/hcaa141.
5
A case of COVID-19 pneumonia with cerebral hemorrhage.
Thromb Res. 2020 Sep;193:22-24. doi: 10.1016/j.thromres.2020.05.050. Epub 2020 May 30.
6
Challenges for the care delivery for critically ill COVID-19 patients in developing countries: the Brazilian perspective.
Crit Care. 2020 Sep 30;24(1):593. doi: 10.1186/s13054-020-03278-7.
7
Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry.
J Clin Anesth. 2020 Dec;67:109976. doi: 10.1016/j.jclinane.2020.109976. Epub 2020 Jul 4.
8
How to evaluate intensive care unit performance during the COVID-19 pandemic.
Rev Bras Ter Intensiva. 2020 Jun;32(2):203-206. doi: 10.5935/0103-507x.20200040. Epub 2020 Jul 13.
9
COVID-19 associated pulmonary thrombosis.
Thromb Res. 2020 Jul;191:151. doi: 10.1016/j.thromres.2020.04.042. Epub 2020 May 1.
10
Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
Thromb Res. 2020 Jul;191:29. doi: 10.1016/j.thromres.2020.04.023. Epub 2020 Apr 20.
引用本文的文献
1
Role of Enhancing Aerobic Capacity in Countering COVID-19-induced Liver Injury in Elderlies.
Endocr Metab Immune Disord Drug Targets. 2024;24(4):418-429. doi: 10.2174/0118715303250788231018080821.
2
COVID-19 in thrombosis research: An editorial perspective.
Thromb Res. 2021 May;201:147-150. doi: 10.1016/j.thromres.2021.03.011. Epub 2021 Mar 24.
3
Late Complications of COVID-19; a Systematic Review of Current Evidence.
Arch Acad Emerg Med. 2021 Jan 20;9(1):e14. doi: 10.22037/aaem.v9i1.1058. eCollection 2021.
4
Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy.
Int J Med Sci. 2021 Jan 1;18(2):314-324. doi: 10.7150/ijms.51935. eCollection 2021.
本文引用的文献
1
Pulmonary embolism in mechanically ventilated patients requiring computed tomography: Prevalence, risk factors, and outcome.
Crit Care Med. 2012 Dec;40(12):3202-8. doi: 10.1097/CCM.0b013e318265e461.
2
Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors.
Crit Care Med. 2005 Jul;33(7):1565-71. doi: 10.1097/01.ccm.0000171207.95319.b2.
Zotero 插件